miR‐31 ameliorates type 2 diabetic vascular damage through up‐regulation of hypoxia‐inducible factor‐1α/vascular endothelial growth factor‐A

AIMS: microRNA may be a new therapeutic direction for diabetes. As a typical tumor marker, miR‐31 is involved in a variety of metabolic diseases, but the specific role is still unclear. This study aimed to investigate the effect of miR‐31 on type 2 diabetes mellitus and its accompanying vascular inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yuan, Du, Ruochen, Wang, Yufei, Yuan, Yitong, Zhang, Yujuan, Wang, Chunfang, Zhang, Xuanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445209/
https://www.ncbi.nlm.nih.gov/pubmed/37394926
http://dx.doi.org/10.1111/jdi.14039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445209/
https://www.ncbi.nlm.nih.gov/pubmed/37394926
http://dx.doi.org/10.1111/jdi.14039

Ejemplares similares